George Perry is dean of the College of Sciences and professor of biology at The University of Texas at San Antonio. Perry is recognized in the field of Alzheimer disease research particularly for his work on oxidative metabolism.
Perry received his bachelor's of arts degree in zoology with high honorsfrom University of CaliforniaSanta Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures.In 1982, Perry joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment.
He is distinguished as one of the top Alzheimer’s disease researchers with over 900 publications, one of the top 100 most-cited scientists in neuroscience and behavior. Perry has been cited over 52,500 times (H=111) and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Chemistry (CChem), Royal Society of Medicine, Royal College of Pathologists, Royal Society of Arts, Manufactures and Commerce (FRSA), Society of Biology(CBio, CSci)and the Linnean Society of London, past-president of the American Association of Neuropathologists, Foreign Correspondent Member of the Spanish Royal Academy of Sciences, Foreign Corresponding Member of the Academy of Sciences of Lisbon, Corresponding member of the Mexican Academy of Sciences and member of the Iberoamerican Molecular Biology Organization. He won the Distinguished Professional Mentor award from the Society for the Advancement of Chicanos and Native Americans in Sciences, Senior Investigator Award of the International College of Geriatric Psychoneuropharmacology, Senior Fulbright Fellow, Golland Award of the Alamo Chapter of Sigma Xiand the Panama National Plaque of Honor for Excellence in Neuroscience.
Perrys research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of metabolic abnormalities.
1. Perry G. Studies on calcium-stimulated oxidations in the sea urchin egg, Ph.D. Thesis. University of California, San Diego, pp 124, 1979.(9)
Books and Editorships:
1. Perry G, Ed. Advances in Behavioral Biology34: Alterations in the Neuronal Cytoskeleton in Alzheimer Disease. Plenum Press, New York, pp 229, 1987.(13)
2. Perry G, Ed. Alzheimer's disease. Clin Neurosci1(4):163-224, 1993.
3. Perry G, Smith MA, Eds. Alzheimer disease. Part of: Frontiers in Bioscience 7, 2002 http://www.bioscience.org/current/special/perry.htm.
4. Smith MA, Perry G, Pryor WA, Eds. Causes and consequences of oxidative stress in Alzheimer’s disease. Free Radic Biol Med 32(11):1049-1083, 2002; 32(12):1264-1282, 2002; 33(1):45-51, 2002; 33(2):173-191; 33(5):620-626; and 33(9):1194-1199, 2002.
5. Smith MA, Zhu X, Perry G, Eds. Signal transduction in Alzheimer’s disease. Neurosignals 11(5):235-298, 2002.
6. Smith MA, Perry G, Zhu X, Eds. Alzheimer’s disease. Acta Neurobiol Exp64(1):1-118, 2004.
7. Smith MA, Moreira PI, Castellani RJ, Perry G, Eds. Amyloid-β: A multifaceted protein, Parts I and II. Brain Pathol14(4):425-452, 2004 and 15(1):66-87, 2005.
8. Smith MA, Perry G, Eds. Role of amyloid-β in Alzheimer disease. Int J Exp Pathol 86(3):131-185, 2005.
9. Perry G, Smith MA, Eds. Imaging in Alzheimer disease. Microsc Res Tech67(3-4):113-217, 2005.
10. Perry G, Avila J, Kinoshita J, Smith MA, Eds. Alzheimer’s Disease: A Century of Scientific and Clinical Research. IOS Press, Amsterdam, pp. 456, 2006, and J Alzheimer’s Dis9(Suppl):1-456,2006.
11. Smith MA, Rao KSJ, Perry G, Eds. Apoptotic mechanism in neurodegenerative diseases. Curr Alzheimer Res3(4):267-408, 2006.
12. Smith MA, Perry G,Zhu X, Haoudi A, Eds. Neurodegenerative diseases: mechanisms and therapies [18 articles]. JBiomed Biotechnol, 2006 http://www.hindawi.com/journals/jbb/volume-2006/si.2.html
13. Zhu X, Perry, G, Smith MA, Eds. Forum Reviews: Neurodegeneration. Antioxidants and Redox Signaling 9(10):1591-1690, 2007.
14. Chauhan A, Ed., Chauhan V, Perry G, Associate Eds. Autism spectrum disorders American J Biochem Biotech, 4(2):61-225, 2008 http://www.scipub.org/scipub/detail_issue.php?V_No=173&j_id=ajbb
15. Avila J, Perry G, Smith MA, Eds. Is tau aggregation toxic or protective? J Alzheimer’s Dis 14(4):363-457, 2008.
16. Maccioni R, Perry G, Eds. Current Hypotheses and Research Milestones inAlzheimer’s Disease. Springer Press,pp. 247, 2009.
17. Zhu X, Beal MF, Wang X, Perry G, Smith MA, Eds. Mitochondria and Neurodegenerative Diseases.J Alzheimer’s Dis 20(suppl 2): S253-S643, 2010.
18. Casadesus G, Ed.; Perry G, Smith MA, Series Eds. Advances in Alzheimer’s Disease1: Handbook of Animal Models in Alzheimer’s Disease. IOS Press, Amsterdam, pp. 340, 2011.
19. Ashford JW, Rosen A, Adamson M, Bayley P, Sabri O, Furst A, Black SE, Weiner M, Eds.; Perry G, Smith MA, Series Eds. Advances in Alzheimer’s Disease2:Handbook of Imaging the Alzheimer Brain.IOS Press, Amsterdam, pp. 808, 2011.
20. Britton G, Smith MA, Perry G, Sambamurti K, Jagannatha Rao KS, Eds. Drug Discovery for Neurodegenerative Diseases: Challenges and Novel Biochemical Targets. J Alzheimer’s Dis24(Suppl2): pp.1-232, 2011.